NYX-MEDICO ApS: Financial statements 2025
CVR: 44123258
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
NYX-MEDICO ApS (CVR 44123258) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -530,915 and a net result of DKK -544,832 compared with DKK -59,682 the year before. Equity in the 2025 report amounted to DKK -144,171.
- Gross Profit
- DKK -530,915
- Profit/Loss
- DKK -544,832
- Equity
- DKK -144,171
- Total Assets
- DKK 46,354
Official annual report
How creditworthy is NYX-MEDICO ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
NYX-MEDICO ApS has published its annual report for 2024. Gross profit came to DKK -48,799, and the net result was DKK -59,682.
As of April 16, 2025, Egil Fabritius Hulgaard has joined the board of directors of NYX-MEDICO ApS.
As of April 16, 2025, Anders Permin has joined the board of directors of NYX-MEDICO ApS.
As of April 16, 2025, Christian Kühl has joined the board of directors of NYX-MEDICO ApS.
As of April 16, 2025, Jacob Boes has joined the board of directors of NYX-MEDICO ApS.
About NYX-MEDICO ApS
NYX-MEDICO ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2023. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Anders Permin. The board consists of Egil Fabritius Hulgaard (chair), Anders Permin, Christian Kühl and Jacob Boes. The company's owners include Tom Hornshøj-Møller, Claus Nicholas Øeland and Permin Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -530,915 and a net result of DKK -544,832 compared with DKK -59,682 the year before. Equity in the 2025 report amounted to DKK -144,171.